[Determination of beta2-microglobulin in breast, lung, colorectal and ENT carcinoma (author's transl)].
Significant increase of plasma level beta2-microglobulin in cancer patients (breast, bronchus, colorectal and ENT) occurs rarely. More, the highest levels observed are within the range of non malignant diseases. We cannot assume that beta2-microglobulin assay will be useful as tumor marker.
D001609:Beta-Globulins / Q000032:analysis*; D001943:Breast Neoplasms / Q000097:blood; D003110:Colonic Neoplasms / Q000097:blood; D004428:Ear Neoplasms / Q000097:blood; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood; D008297:Male; D009369:Neoplasms / Q000097:blood*; D009669:Nose Neoplasms / Q000097:blood; D001613:beta 2-Microglobulin / Q000032:analysis*
D001609:Beta-Globulins; D001613:beta 2-Microglobulin
Dosage de la beta2-microglobuline dans les cancers du sein, du poumon, du côlon et de la sphère ORL.